€ 0
Call for proposals to support the development of innovative medical countermeasures for chemical, biological, radiological and nuclear threats (HERA)
https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/EU4H-2025-HERA-PJ-1-b?order=DESC&pageNumber=1&pageSize=50&sortBy=startDate&isExactMatch=true
Overview
| Donor: | European Commission (EC) - EU4Health Programme (EU4H) |
| Application procedure: | Full Proposal |
| Donor base: | Belgium |
| Reference number: | EU4H-2025-HERA-PJ-1-b |
| Eligible applicants: | Non-Profit Organisation, Social Business |
| Deadline: | 04.12.2025 |
Financial details
| Grant size: | Medium - up to $1,000,000 |
| Minimum grant size: | - |
| Total available budget: | 1.000.000€ |
| Funding type: | Grants |
| Maximum grant size: | - |
| Funding ratio: | up to 100% |
Sectors
- Capacity Building
- Health
- Research, Technology & Innovation
Project Locations
Europe
Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Moldova, Montenegro, Poland, Romania, Slovakia, Slovenia, Ukraine
Description
1) Objective
This action is expected to increase the preparedness of the Union to respond to CBRN threats and improve the availability of medical countermeasures against these threats. It should advance one or more medical countermeasures against CBRN threats along the steps towards regulatory approval and market readiness. For Personal Protective Equipment (‘PPE’), the focus is on reusable respiratory PPE and protection suits.
The range of activities include an end-to-end approach to bridge the gap between advanced research, innovation, market access and deployment by supporting:
- Advanced research and development (‘R&D’) to support the development of medical countermeasures;
- Involving end users and security practitioners to bring the research products closer to market readiness; and
- Support research into market readiness or facilitate tech and entrepreneurial skills development.
The objective is to improve the Union’s readiness to respond to intentional health threats, including cross-border ones, by supporting the development of medical countermeasures to biological, chemical and radio-nuclear agents for which there currently are no or only limited treatment options.
2) Eligibility
Eligibility is limited to legal entities (public or private bodies) established in one of the eligible countries.
3) Location
Actions must take place in EU member states plus Ukraine, Moldova, Bosnia and Herzegovina and Montenegro.
4) Budget
The total available funding is €1,000,000.
5) Application
The application deadline is 4 December 2025. A full proposal must be submitted. All application templates can be downloaded at the given website.